Jessica J Alm
Overview
Explore the profile of Jessica J Alm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
779
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rathod B, Desai S, Samvelyan H, Bock L, Wu J, Ohlsson C, et al.
Bone
. 2024 Aug;
188:117223.
PMID: 39111379
Tartrate-resistant acid phosphatase (TRAP) serum levels reflect osteoclast number, bone remodeling activity, and fracture risk. Deletion or loss of function of TRAP results in short stature in mice and man....
2.
Aguilera K, Bladh O, Marking U, Greilert Norin N, Rihani A, Ujvari D, et al.
Lancet Reg Health Eur
. 2024 Mar;
38:100872.
PMID: 38476745
No abstract available.
3.
Wang S, Nikamo P, Laasonen L, Gudbjornsson B, Ejstrup L, Iversen L, et al.
EMBO Mol Med
. 2024 Feb;
16(3):596-615.
PMID: 38379095
Psoriatic arthritis mutilans (PAM) is the rarest and most severe form of psoriatic arthritis, characterized by erosions of the small joints and osteolysis leading to joint disruption. Despite its severity,...
4.
Bladh O, Greilert-Norin N, Havervall S, Marking U, Aguilera K, Alm J, et al.
N Engl J Med
. 2023 Oct;
389(17):1626-1628.
PMID: 37888924
No abstract available.
5.
Blom K, Bladh O, Havervall S, Marking U, Greilert Norin N, Alm J, et al.
Lancet Reg Health Eur
. 2023 Sep;
33:100725.
PMID: 37680234
No abstract available.
6.
Marking U, Bladh O, Havervall S, Greilert-Norin N, Gordon M, Alm J, et al.
Lancet Infect Dis
. 2023 Jul;
23(8):e272-e273.
PMID: 37453441
No abstract available.
7.
Marking U, Havervall S, Greilert Norin N, Bladh O, Christ W, Gordon M, et al.
Nat Commun
. 2023 Mar;
14(1):1577.
PMID: 36949041
Vaccination offers protection against severe COVID-19 caused by SARS-CoV-2 omicron but is less effective against infection. Characteristics such as serum antibody titer correlation to protection, viral abundance and clearance of...
8.
Hober A, Tran-Minh K, Foley D, McDonald T, Vissers J, Pattison R, et al.
Elife
. 2021 Nov;
10.
PMID: 34747696
Reliable, robust, large-scale molecular testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential for monitoring the ongoing coronavirus disease 2019 (COVID-19) pandemic. We have developed a scalable analytical...
9.
Costantini A, Alm J, Tonelli F, Valta H, Huber C, Tran A, et al.
J Bone Miner Res
. 2020 Sep;
36(2):283-297.
PMID: 32916022
Spondyloepimetaphyseal dysplasias (SEMDs) are a heterogeneous group of disorders with variable growth failure and skeletal impairments affecting the spine and long bone epiphyses and metaphyses. Here we report on four...
10.
Makitie R, Kampe A, Costantini A, Alm J, Magnusson P, Makitie O
J Bone Miner Res
. 2020 Jan;
35(5):901-912.
PMID: 31968132
Recent advancements in genetic research have uncovered new forms of monogenic osteoporosis, expanding our understanding of the molecular pathways regulating bone health. Despite active research, knowledge on the pathomechanisms, disease-specific...